U.C.S. ME/CFS Act

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

D RaskinSponsor

51 cosponsors · 45 D, 6 R

0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Understanding COVID-19 Subsets and ME/CFS Act or the U.C.S. ME/CFS Act

What it does: CRS summary · Introduced in House · May 28, 2020

Understanding COVID-19 Subsets and ME/CFS Act or the U.C.S. ME/CFS Act

This bill requires the National Institutes of Health to support research on myalgic encephalomyelitis/chronic fatigue syndrome among COVID-19 (i.e., coronavirus disease 2019) patients and survivors. This is a serious, chronic, and multisystem disease associated with survivors of viral infections. In addition, the Department of Health and Human Services may carry out a public awareness campaign about post-viral chronic neuroimmune diseases.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: U.C.S. ME/CFS Act

Also known as: Understanding COVID–19 Subsets and ME/CFS Act

Latest action (May 28, 2020): Referred to the House Committee on Energy and Commerce.

Policy area: Health · Origin: House · Introduced: May 28, 2020

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.